CytoSorbents Corp. announced the launch of its newly redesigned and consolidated website. The theme of “Working to Save Lives Together” highlights two decades of successful collaboration with the international medical and research communities to continuously refine how its therapies are being used to help patients survive life-threatening illnesses.
The new website unifies the Princeton-based firm’s corporate and product information into a single, cohesive and comprehensive information hub for health care professionals, investors, and other key stakeholders. Visitors will find a streamlined modern design, intuitive navigation, and extensive content on our company, technology, therapies, pipeline that includes DrugSorb™-ATR and HemoDefend-BGA™, clinical studies, investor conferences and much more.
Key features of the new website:
User-friendly layout and intuitive navigation
Enhanced Easy-to-Understand Content
News and Updates
Comprehensive and Searchable Resource Library
Introduction to Our Experts
Voices Around the World
Dedicated Investor Relations site
Improved Contact Forms
“We are grateful to all of the pioneering physicians, nurses, perfusionists, researchers, and other health care professionals who use our therapies in daily clinical practice or who have contributed to the many studies and the more than 1,000 references that can be found in our CytoSorb literature database on our new website,” Christian Steiner, executive vice president of sales and marketing of CytoSorbents, stated.
